Sensus Healthcare (SRTS) Net Income towards Common Stockholders Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -304.85% |
| Sep 30, 2025 | -177.61% |
| Jun 30, 2025 | -164.33% |
| Mar 31, 2025 | -213.10% |
| Dec 31, 2024 | -63.28% |
| Sep 30, 2024 | 183.74% |
| Jun 30, 2024 | 524.21% |
| Mar 31, 2024 | 220.06% |
| Dec 31, 2023 | 48.82% |
| Sep 30, 2023 | -179.33% |
| Jun 30, 2023 | -110.78% |
| Mar 31, 2023 | 99.70% |
| Dec 31, 2022 | -46.80% |
| Sep 30, 2022 | 837.95% |
| Jun 30, 2022 | 1,363.08% |
| Mar 31, 2022 | -56,517.94% |
| Dec 31, 2021 | 1,945.20% |
| Sep 30, 2021 | 108.55% |
| Jun 30, 2021 | 89.16% |
| Mar 31, 2021 | 68.92% |
| Dec 31, 2020 | -74.98% |
| Sep 30, 2020 | -212.10% |
| Jun 30, 2020 | -2,392.31% |
| Mar 31, 2020 | -69.12% |
| Dec 31, 2019 | 919.62% |
| Sep 30, 2019 | -59.44% |
| Jun 30, 2019 | 120.77% |
| Mar 31, 2019 | -88.38% |
| Dec 31, 2018 | 124.94% |
| Sep 30, 2018 | 52.56% |
| Jun 30, 2018 | 29.24% |
| Mar 31, 2018 | 28.38% |
| Jun 30, 2017 | -117.51% |